Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured...
Se muestra el contenido original; la traduccion localizada aun no esta disponible.
Qué ocurrió
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured...
Por que importa
The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.
Entidades afectadas
Ver evidencia
1 articulos · 1 informe original · 1 independientes
- U.S. Department of JusticeFuente primaria · Respalda · EN · 100%Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program ↗
Afirmaciones
- Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program Observado
Conflictos
No se detectaron conflictos importantes en la evidencia disponible.
Cronología
- Primera publicación
Movimiento del mercado posterior al evento
La reacción del mercado aún no está disponible para este activo y periodo.